Independent causal effect of migraines on Alzheimer's disease risk: a multivariate Mendelian randomization study

Chengfeng Xu1, Wen Wu2, Yuchao Fan1

  • 1Department of Anesthesiology, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, China.

PubMed
Abstract

Insights

Genetically predicted migraine is linked to an increased risk of Alzheimer's Disease (AD). However, this association disappears when accounting for factors like blood pressure and tumor necrosis factor alpha.

Area of Science:

  • Neuroscience
  • Genetics
  • Epidemiology

Background:

  • Observational studies on migraine and Alzheimer's Disease (AD) have yielded contradictory results.
  • Previous findings were limited by confounding factors and potential reverse causation.

Purpose of the Study:

  • To investigate the causal relationship between migraine and Alzheimer's Disease (AD) risk.
  • To assess the independent impact of migraine on AD risk using Mendelian Randomization.

Main Methods:

  • Utilized Univariable Mendelian Randomization (UVMR) with large case-control datasets for migraine and AD.
  • Performed meta-analysis to synthesize results from multiple cohorts.
  • Employed Multivariable Mendelian Randomization (MVMR) to adjust for 35 potential AD risk factors.

Main Results:

  • Meta-analysis suggested a causal link between genetically predicted migraine and heightened AD risk (OR [95% CI]: 1.54 [1.18, 2.00], p < 0.01).
  • After adjusting for diastolic blood pressure and tumor necrosis factor alpha, the association between migraine and AD risk was no longer significant.

Conclusions:

  • Genetically predicted migraine shows a significant correlation with elevated Alzheimer's Disease risk.
  • The independent effect of migraine on AD risk is not supported after controlling for key confounding factors.